Abstract
This paper present simple method to study and to compare the infection dynamics between countries based on curve fitting to the publicly shared data of COVID-19 confirmed infections reported by them. Presented method was tested using data from 80 countries from 6 regions. We found that Johnson Cumulative Distribution Functions (CDF) are extremely well fitted to the data (R2>0.99) and that Johnson CDF is much better fitted to the data at its tails than both commonly used Normal and Lognormal CDF. Fitted Johnson CDFs can be used to obtain basic parameters of the infection wave, such as the percentage of the population infected during the infection wave, day of the start, peak and the end of the infection wave, as well as the duration of the infections wave and the duration of the wave increase and decrease. These parameters may be easily biologically interpreted and used both in describing the infection wave dynamics and in further statistical analysis. The usefulness of the obtained parameters was demonstrated on two examples: the analysis of the relation of the Gross Domestic Product (GDP) per capita and the analysis of the population density on the percentage of the population infected during infection wave, the day of the start, and the duration of the infection wave in analyzed countries. We found that all of the abovementioned parameters were significantly dependent on the GDP per capita, while only the percentage of population infected was significantly dependent on the population density in analyzed countries. Also, if used with caution, presented method has some limited ability to predict the future trajectory and parameters of the ongoing infection wave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was financed partly by the statutory funds of the Institute of Nature Conservation, Polish Academy of Sciences and partly by the statutory funds of the Faculty of Applied Mathematics, AGH University of Science and Technology.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in this study was obtained from Our World in Data COVID-19 dataset and are available at https://ourworldindata.org/coronavirus